Moderna, Inc.
(NASDAQ : MRNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -5.93%68.351.0%$1416.69m
BIIBBiogen, Inc. -1.64%304.991.5%$624.23m
REGNRegeneron Pharmaceuticals, Inc. -0.33%430.182.6%$523.24m
AMGNAmgen, Inc. -2.91%197.581.3%$511.11m
ILMNIllumina, Inc. -0.06%259.773.5%$395.60m
VRTXVertex Pharmaceuticals, Inc. -1.72%219.451.9%$342.41m
MRNAModerna, Inc. -12.58%22.870.0%$330.43m
ALXNAlexion Pharmaceuticals, Inc. -1.06%91.122.0%$218.38m
CODXCo-Diagnostics, Inc. -16.54%13.320.0%$206.46m
AAgilent Technologies, Inc. -2.18%75.741.6%$166.07m
EXASEXACT Sciences Corp. 0.71%81.4024.0%$164.79m
BMRNBioMarin Pharmaceutical, Inc. -1.31%88.644.3%$113.23m
INCYIncyte Corp. -2.62%73.862.5%$107.50m
SGENSeattle Genetics, Inc. 0.11%108.436.1%$106.01m
NVAXNovavax, Inc. 23.39%14.56184.0%$81.11m

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.